Recro Pharma is a specialty pharmaceutical company that focuses on developing medical products for hospitals and other acute care settings.Read more
Recro Pharma's revenue is the ranked 8th among it's top 10 competitors. The top 10 competitors average 579.2M. Over the last four quarters, Recro Pharma's revenue has grown by 17.6%. Specifically, in Q1 2022's revenue was $21.2M; in Q4 2021, it was $22.3M; in Q3 2021, it was $18.2M; in Q2 2021, Recro Pharma's revenue was $18M.